These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37949354)

  • 21. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
    Vass CM; Rigby D; Payne K
    Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient preferences for diabetes treatment attributes and drug classes.
    Flood EM; Bell KF; de la Cruz MC; Ginchereau-Sowell FM
    Curr Med Res Opin; 2017 Feb; 33(2):261-268. PubMed ID: 27779433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review.
    Zhou M; Thayer WM; Bridges JFP
    Pharmacoeconomics; 2018 Feb; 36(2):175-187. PubMed ID: 28975582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment.
    Brinkmann M; Diedrich L; Hemmerling M; Krauth C; Robra BP; Stahmeyer JT; Dreier M
    Value Health; 2023 Jan; 26(1):104-114. PubMed ID: 36031478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment.
    Guo N; Marra CA; FitzGerald JM; Elwood RK; Anis AH; Marra F
    Value Health; 2011; 14(6):937-43. PubMed ID: 21914516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches.
    Boeri M; Saure D; Schacht A; Riedl E; Hauber B
    Pharmacoeconomics; 2020 Jun; 38(6):593-606. PubMed ID: 32128726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in preferences for outcomes of integrated care for persons with multiple chronic diseases: a latent class analysis of a discrete choice experiment.
    Hoedemakers M; Karimi M; Jonker M; Tsiachristas A; Rutten-van Mölken M
    Qual Life Res; 2022 Sep; 31(9):2775-2789. PubMed ID: 35585287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preference Variation: Where Does Health Risk Attitude Come Into the Equation?
    Huls SPI; Veldwijk J; Swait JD; Viberg Johansson J; Ancillotti M; de Bekker-Grob EW
    Value Health; 2022 Dec; 25(12):2044-2052. PubMed ID: 35750590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preference heterogeneity in health valuation: a latent class analysis of the Peru EQ-5D-5L values.
    Karim S; Craig BM; Tejada RA; Augustovski F
    Health Qual Life Outcomes; 2023 Jan; 21(1):1. PubMed ID: 36593473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania.
    Simons G; Veldwijk J; DiSantostefano RL; Englbrecht M; Radawski C; Bywall KS; Valor Méndez L; Hauber B; Raza K; Falahee M
    Rheumatology (Oxford); 2023 Feb; 62(2):596-605. PubMed ID: 36068022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists.
    Hifinger M; Hiligsmann M; Ramiro S; Watson V; Severens JL; Fautrel B; Uhlig T; van Vollenhoven R; Jacques P; Detert J; Canas da Silva J; Scirè CA; Berghea F; Carmona L; Péntek M; Keat A; Boonen A
    Ann Rheum Dis; 2017 Jan; 76(1):126-132. PubMed ID: 27190098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home.
    Goossens LM; Utens CM; Smeenk FW; Donkers B; van Schayck OC; Rutten-van Mölken MP
    Value Health; 2014 Jul; 17(5):588-96. PubMed ID: 25128052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study.
    Poulos C; Wakeford C; Kinter E; Mange B; Schenk T; Jhaveri M
    Mult Scler J Exp Transl Clin; 2020; 6(1):2055217320910778. PubMed ID: 32215218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantifying preferences for asthma control in parents and adolescents using best-worst scaling.
    Ungar WJ; Hadioonzadeh A; Najafzadeh M; Tsao NW; Dell S; Lynd LD
    Respir Med; 2014 Jun; 108(6):842-51. PubMed ID: 24780719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis.
    Tervonen T; Vora P; Seo J; Krucien N; Marsh K; De Caterina R; Wissinger U; Soriano Gabarró M
    Patient; 2021 Sep; 14(5):661-672. PubMed ID: 33829397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling.
    Aschmann HE; Puhan MA; Robbins CW; Bayliss EA; Chan WV; Mularski RA; Wilson RF; Bennett WL; Sheehan OC; Yu T; Yebyo HG; Leff B; Tabano H; Armacost K; Glover C; Maslow K; Mintz S; Boyd CM
    Health Qual Life Outcomes; 2019 Dec; 17(1):186. PubMed ID: 31856842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-Preference Diagnostics: Adapting Stated-Preference Methods to Inform Effective Shared Decision Making.
    Gonzalez Sepulveda JM; Johnson FR; Reed SD; Muiruri C; Hutyra CA; Mather RC
    Med Decis Making; 2023 Feb; 43(2):214-226. PubMed ID: 35904149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient and caregiver preferences for the potential benefits and risks of a seizure forecasting device: A best-worst scaling.
    Janse SA; Dumanis SB; Huwig T; Hyman S; Fureman BE; Bridges JFP
    Epilepsy Behav; 2019 Jul; 96():183-191. PubMed ID: 31150998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do people have differing motivations for participating in a stated-preference study? Results from a latent-class analysis.
    Hollin IL; Janssen E; Kelley MA; Bridges JFP
    BMC Med Inform Decis Mak; 2021 Feb; 21(1):44. PubMed ID: 33549068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.